Cited by 435Pharmacology and Obesity TreatmentRegulation of Appetite and ObesityBariatric Surgery and Outcomes

Medicinal strategies in the treatment of obesity

Bray, George A., Tartaglia, Louis A.·2000·Nature

Abstract

When prevention fails, medicinal treatment of obesity may become a necessity. Any strategic medicinal development must recognize that obesity is a chronic, stigmatized and costly disease that is increasing in prevalence. Because obesity can rarely be cured, treatment strategies are effective only as long as they are used, and combined therapy may be more effective than monotherapy. For a drug to have significant impact on body weight it must ultimately reduce energy intake, increase energy expenditure, or both. Currently approved drugs for long-term treatment of obesity include sibutramine, which inhibits food intake, and orlistat, which blocks fat digestion.

Integrity signals

Registry

Crossref · 10.1038/35007544

Cites

93 of 93 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Inhibiting reuptake of norepinephrine, dopamine, and serotonin is the strategy employed by drugs such as sibutramine, which are effective but have side effects such as increased blood pressure and heart rate.

    “inhibiting their reuptake is the strategy employed by drugs such as sibutramine, which have proven effective but have side effects such as increased blood pressure and heart rate [40].”

    From Regulation of obesity and insulin resistance by nitric oxide (2014) · cites this paper as [40]

  • Orlistat promotes weight loss, but side effects caused discontinuation of the medication in many patients.

    “orlistat promotes weight loss; however, side effects caused discontinuation of the medication in many patients [40].”

    From Regulation of obesity and insulin resistance by nitric oxide (2014) · cites this paper as [40]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Bray, G. A., & Tartaglia, L. A.
Affiliations
  • Pennington Biomedical Research Center (US)
  • Takeda Oncology (United States) (US)
Venue
Nature
Published
2000-04
Volume
404
Issue
6778
Pages
672-677
ISSN
  • 0028-0836 (ISSN-L)
  • 1476-4687
OpenAlex
W1489925379
Cited by
432
References
93
Citations by year
2026: 1 · 2025: 4 · 2024: 4 · 2023: 3 · 2022: 6 · 2021: 15 · 2020: 11 · 2019: 14 · 2018: 12 · 2017: 14 · 2016: 19 · 2015: 11 · 2014: 25 · 2013: 12 · 2012: 23
FWCI
4.09
Type
journal article
Language
en
Open access
closed
Locations
  • Nature (publishedVersion)
  • PubMed (publishedVersion)
  • RePEc: Research Papers in Economics (submittedVersion)
Topics
  • Health Sciences › Medicine › Pharmacology › Pharmacology and Obesity Treatment
  • Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
  • Health Sciences › Medicine › Surgery › Bariatric Surgery and Outcomes
Keywords
obesity, anti-obesity drugs, sibutramine, orlistat, energy expenditure, energy intake, combination therapy, chronic disease, obesity treatment strategies
MeSH terms
Adipose Tissue, Dietary Fats, Eating, Energy Metabolism, Humans, Intestinal Absorption, Neuropeptides, Obesity, Anti-Obesity Agents

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review